Thanks to colleagues who took part in the 2022 Great Place to Work survey, Oxford PharmaGenesis is ranked the UK’s no. 6 Best Workplace for Women (large company category). Executive Director Catherine Hill sits on the Oxford PharmaGenesis Board and co-leads the Regional Leadership Team for Europe. Here, she tells us about her own journey […]
Exciting news! Our poster presented at #ISMPPEurope2023 won the award for 'most reflective of meeting theme'. Using #AI techniques, we discovered that exaggerated language in news articles played a key role in viral spread of information. View it here! https://t.co/6WUD7Y5iCB https://t.co/V6ZX23uNKm
How can we ensure that clinical research becomes more accessible? Take part in our #ISMPPEurope2023 roundtable to explore the changing attitudes of pharmaceutical companies, the increased use of plain language documents and more. Join ‘Much ado about access’ with @_OpenPharma! https://t.co/zd6EilIumH
Here's what you need to know about the role of patients as authors in #MedicalPublications according to the updates to the #GPP2022 guidelines. What are your thoughts on the changes to GPP? Comment below or drop by booth 1 at #ISMPPEurope2023 for a chat! https://t.co/PEcpQpmsfU https://t.co/1vRdllm2xx
This year we’re donating 500 festive dinners to our local communities. Wishing you all peace, goodwill and a Happy New Year! https://t.co/wVXVCP3Jz6
24-25 January 2023
2023 European Meeting of ISMPP, London UK
Can we ever have true creativity without true inclusivity? How should the pharmaceutical industry respond to health equity issues? Do digital enhancements improve accessibility or do they just paper over the gap?
Effective innovation happens when we ask big questions. It’s part of what makes Oxford PharmaGenesis an award-winning, independent, global HealthScience communications consultancy. We innovate for clients through our transformative services. We offer expertise in publications, strategic medical communications, informatics and data science, patient engagement, value demonstration, Open Pharma, social media and more.
Join our healthy debate at the 2023 European Meeting of ISMPP and explore new frontiers with Oxford PharmaGenesis.
Do you want to feel valued for who you really are? Oxford PharmaGenesis will be at the Working in and around #MedComms careers event! Whether you’re new to medical communications or looking to advance your career, we want to hear about your unique skills and experience. Visit our booth to chat about our award-winning HealthScience consultancy, plus our exciting roles, development opportunities and one-of-a-kind company culture.
Supporting research at the University of Oxford: Oxford PharmaGenesis funds studentship at Green Templeton College to explore the impact of race and ethnicity on emerging digital techniques in dermatology
Oxford PharmaGenesis is delighted to support a funded DPhil studentship in Translational Health Sciences in collaboration with Green Templeton College at the University of Oxford, UK. The studentship will examine the importance of diversity in dermatology, particularly when applying emerging techniques in artificial intelligence and machine learning. Applications are now open. Please help to spread […]
The MM+M Agency 100 report: Oxford PharmaGenesis recognized as industry leader for the second year running
For the second year running, media brand Medical Marketing and Media (MM+M) has listed Oxford PharmaGenesis in its Agency 100 report – the annual definitive ‘who’s who’ ranking of the healthcare sector’s top marketing firms in North America.
Oxford PharmaGenesis is proud to sponsor the latest CISCRP clinical trials education campaign to raise awareness and understanding of clinical research among minority urban communities in cities across the USA and among the wider general public.
Oxford PharmaGenesis has been shortlisted for the Communiqué Awards 2022 for the Award for Excellence in Public Health Communications for MS Brain Health, on behalf of Oxford Health Policy Forum. This global policy initiative has changed the way that leading multiple sclerosis (MS) experts view best practice in MS care.